Cargando…
Protection against Radiotherapy-Induced Toxicity
Radiation therapy is a highly utilized therapy in the treatment of malignancies with up to 60% of cancer patients receiving radiation therapy as a part of their treatment regimen. Radiation therapy does, however, cause a wide range of adverse effects that can be severe and cause permanent damage to...
Autores principales: | Hall, Susan, Rudrawar, Santosh, Zunk, Matthew, Bernaitis, Nijole, Arora, Devinder, McDermott, Catherine M, Anoopkumar-Dukie, Shailendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039571/ https://www.ncbi.nlm.nih.gov/pubmed/27399787 http://dx.doi.org/10.3390/antiox5030022 |
Ejemplares similares
-
Drivers of Radioresistance in Prostate Cancer
por: King, Liam, et al.
Publicado: (2022) -
The SAMe-TT(2)R(2) Score Predicts Warfarin Control in an Australian Population with Atrial Fibrillation
por: Bernaitis, Nijole, et al.
Publicado: (2019) -
The Use of Fish Oil with Warfarin Does Not Significantly Affect either the International Normalised Ratio or Incidence of Adverse Events in Patients with Atrial Fibrillation and Deep Vein Thrombosis: A Retrospective Study
por: Pryce, Rebecca, et al.
Publicado: (2016) -
Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study
por: King, Liam, et al.
Publicado: (2020) -
Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore
por: Bernaitis, Nijole, et al.
Publicado: (2018)